Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in: Digestive Diseases and Sciences 3/2007

01-03-2007 | Original Article

High Proportions of Proinflammatory Bacteria on the Colonic Mucosa in a Young Patient with Ulcerative Colitis as Revealed by Cloning and Sequencing of 16S rRNA Genes

Authors: Mei Wang, Göran Molin, Siv Ahrné, Diya Adawi, Bengt Jeppsson

Published in: Digestive Diseases and Sciences | Issue 3/2007

Login to get access

Abstract

The pathogenesis of ulcerative colitis (UC) remains unknown. It is thought to be due to an abnormal and uncontrolled immune response to normally occurring constituents of the intestine. Microbial agents appear to be involved in the pathogenesis and intestinal bacteria seem to be an important factor in the development and chronicity. The aim of this study was to investigate the colonic microbiota of a patient with UC. The colonic tissues were taken during surgery from a 12-year-old girl suffering from UC. The microbiota on the colonic samples was studied by cloning and sequencing of amplified 16S rRNA genes. Compared with healthy subjects, alteration of the dominant bacterial group was observed in the UC patient. We found a high incidence of Enterobacteriaceae, Bacteroides fragilis, and the single phylotype of the Faecalibacterium prausnitzii-like “Butyrate-producing bacterium” L2-6. Furthermore, there was a substantial presence of Pseudomonas aeruginosa in the present case of UC. The high proportion of adverse proinflammatory species is striking in the present case compared with more normal situations. Even if those bacteria are not the cause of the UC, they most probably enhance the symptoms of the disease.
Literature
1.
Shivananda S, Lennard-Jones J, Logan R, Fear N, Price A, Carpenter L, van Blauthenstein M (1996) Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European collaborative study on inflammatory bowel disease (EC-IBD). Gut 39:690–697PubMed
2.
Ardizzone S, Bollani S, Manzionna G, Bianchi Porro G (1999) Inflammatory bowel disease approaching the 3rd millennium: pathogenesis and therapeutic implications. Eur J Gastroenterol Hepatol 11:17–32CrossRef
3.
4.
Schultz M, Sartor RB (2000) Probiotics and inflammatory bowel diseases. Am J Gastroenterol 95:S19–S21PubMedCrossRef
5.
Bruzzese, E, Canani RB, De Marco G, Guarino A (2004) Microflora in inflammatory bowel diseases: a pediatric perspective. J Clin Gastroenterol 38:S91–S93PubMedCrossRef
6.
Roediger WE, Duncan A, Kapaniris O, Millard S (1993) Reducing sulphur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis. Gastroenterology 104: 802– 809PubMed
7.
Schultsz C, Van Den Berg FM, Ten Kate FW, Tytgat GNJ, Dankert J (1999) The intestinal mucus layer from patients with inflammatory bowel disease harbours high numbers of bacteria compared with controls. Gastroenterology 117:1089–1097PubMedCrossRef
8.
Sartor RB (2004) Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: antibiotics, probiotics, and prebiotics. Gastroenterology 126:1620–1633PubMedCrossRef
9.
Poxton IR, Brown R, Sawyerr A, Ferguson A (1997) Mucosa-associated bacterial flora of the human colon. J Med Microbiol 46:85–91PubMedCrossRef
10.
Giaffer MH, Holdsworth CD, Duerden BI (1992) Virulence properties of Escherichia coli strains isolated from patients with inflammatory bowel disease. Gut 33:646–650PubMed
11.
Darfeuille-Michaud A, Neut C, Barnich N, Lederman E, Di Martino P, Desreumaux P, Gambiez L, Joly B, Cortot A, Colombel JF (1998) Presence of adherent Escherichia coli strains in ileal mucosa of patient with Crohn's disease. Gastroenterology 115:1405– 1413PubMedCrossRef
12.
Balish E, Warner T (2002) Enterococcus faecalis induces inflammatory bowel disease in interleukin-10 knockout mice. Am J Pathol 160:2253–2255PubMed
13.
Hugenholtz P, Goebel BM, Pace NR (1998) Impact of culture-independent studies on the emerging phylogenetic view of bacterial diversity. J Bacteriol 180:4765–4774PubMed
14.
Suau A, Bonnet R, Sutren M, Godon JJ, Gibson GR, Collins MD, Doré J (1999) Direct analysis of genes encoding 16S rRNA from complex communities reveals many novel molecular species within the human gut. Appl Environ Microbiol 65:4799–4807PubMed
15.
Hold GL, Pryde SE, Russell VJ, Furrie E, Flint, HJ (2002) Assessment of microbial diversity in human colonic samples by 16S rDNA sequence analysis. FEMS Microbiol Ecol 39:33–39CrossRefPubMed
16.
Wang X, Heazlewood SP, Krause DO, Florin TH (2003) Molecular characterization of microbial species that colonize human ileal and colonic mucosa by using 16S rDNA sequence analysis. J Appl Microbiol 95:508–520PubMedCrossRef
17.
Wang M, Ahrné S, Jeppsson B, Molin G (2005) Comparison of bacterial diversity along the human intestinal tract by direct cloning and sequencing of 16S rRNA genes. FEMS Microbiol Ecol 54:219–231PubMedCrossRef
18.
Hultman T, Bergh S, Moks T, Uhlén M (1991) Bidirectional solid-phase sequencing of in vitro-amplified plasmid DNA. BioTechniques 10:84–93PubMed
19.
Altschul SF, Gish W, Miller W, Meyers EW, Lipman DJ (1990) Basic local alignment search tool. J Mol Biol 215:403–410PubMed
20.
Thompson JD, Gibson TJ, Plewniak F, Jeanmougin F, Higgins DG (1997) The CLUSTAL_X Windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25:4876–4882PubMedCrossRef
21.
Hall TA (1999) BioEdit: a user-friendly biological sequence alignment editor and analysis program for Window 95/98/NT. Nucleic Acids Symp Ser 41:95–98
22.
Saitou N, Nei M (1987) The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol Biol Evol 4:406–425PubMed
23.
Page RDM (1996) TREEVIEW: an application to display phylogenetic trees on personal computers. Comput Applic Biosci 12:357–358
24.
Cole JR, Chai B, Marsh TL, Farris RJ, Wang Q, Kulam SA, Chandra S, McGarrell DM, Schmidt TM, Garrity GM, Tiedje JM (2003) The Ribosomal Database Project (RDP-II): previewing a new autoaligner that allows regular updates and the new prokaryotic taxonomy. Nucleic Acids Res 31:442–443PubMedCrossRef
25.
Collins MD, Lawson PA, Willems A, Cordoba JJ, Fernandez−Garayzabal J, Garcia P, Cai J, Hippe H, Farrow JA (1994) The phylogeny of genus Clostridium: proposal of five new genera and eleven new species combinations. Int J Syst Bacteriol 44:812–826PubMedCrossRef
26.
Barcenilla A, Pryde SE, Martin JC, Duncan SH, Stewart CS, Henderson C, Flint HJ (2000) Phylogenetic relationships of butyrate-producing bacteria from the human gut. Appl Environ Microbiol 66:1654–1661PubMedCrossRef
27.
Sartor RB, Rath HC, Sellon RK (1996) Microbial factors in chronic intestinal inflammation. Curr Opin Gastroenterol 12:327–333CrossRef
28.
Rutgeerts P, Geboes K, Peeters M, Hiele M, Penninckx F, Aerts R, Kerremans R, Vantrappen G (1991) Effect of faecal stream diversion on recurrence of Crohn's disease in the neoterminal ileum. Lancet 338:771–774PubMedCrossRef
29.
Sellon RK, Tonkonogy S, Schultz M, Dieleman LA, Grenther W, Balish E, Rennick DM, Sartor RB (1998) Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 66:5224–5231PubMed
30.
Ehrhardt RO, Lúdvíksson BR, Gray B, Neurath M, Strober W (1997) Induction and prevention of colonic inflammation in IL-2-deficient mice. J Immunol 158:566–573PubMed
31.
Rossolini GM, Mantengoli E (2005) Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 11(Suppl 4):17–32PubMedCrossRef
32.
Navon-Venezia S, Ben-Ami R, Carmeli Y (2005) Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting. Curr Opin Infect Dis 18:306– 313PubMedCrossRef
33.
Burke DA, Axon ATR (1987) Ulcerative colitis and Escherichia coli with adhesive properties. J Clin Pathol 40:782–786PubMed
34.
Burke DA, Axon ATR (1988) Adhesive E. coli in inflammatory bowel disease and infected diarrhoea. BMJ 297:102–104PubMedCrossRef
35.
Schultsz C, Moussa M, van Ketel R, Tytgat GNJ, Dankert J (1997) Frequency of pathogenic and enteroadherent Escherichia coli in patients with inflammatory bowel disease and controls. J Clin Pathol 50:573–579PubMed
36.
Walmsley RS, Anthony A, Sim R, Pounder RE, Wakefield AJ (1998) Absence of Escherichia coli, Listeria monocytogenes, and Klebsiella pneumoniae antigens within inflammatory bowel disease tissues. J Clin Pathol 51:657–661PubMedCrossRef
37.
Holdeman LV, Good IJ, Moore WEC (1976) Human fecal flora: variation in bacterial composition within individuals and a possible effect of emotional stress. Appl Environ Microbiol 31:359– 375PubMed
38.
Rath HC, Wilson KH, Sartor RB (1999) Differential induction of colitis and gastritis in HLA-B27 transgenic rats selectively colonized with Bacteroides vulgatus or Escherichia coli. Infect Immun 67:2969–2974PubMed
39.
Rath HC, Herfarth HH, Ikeda JS, Grenther WB, Hamm Jr TE, Balish E, Taurog JD, Hammer RE, Wilson KH, Sartor RB (1996) Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis, and arthritis in HLA-B27/human β2 microglobulin transgenic rats. J Clin Invest 98:945–953PubMedCrossRef
40.
Matsuda H, Fujiyama Y, Andoh A, Ushijima T, Kajinami T, Bamba T (2000) Characterization of antibody responses against rectal mucosa-associated bacterial flora in patients with ulcerative colitis. J Gastroenterol Hepatol 15:61–68PubMedCrossRef
41.
Polk FB, Kasper DL (1996) Bacteroides fragilis subspecies in clinical isolates. Ann Intern Med 86:569–571
42.
Redondo MC, Arbo MD, Grindlinger J, Snydman DR (1995) Attributable mortality of bacteremia associated with the Bacteroides fragilis group. Clin Infect Dis 20:1492–1496PubMed
43.
Sanfilippo L, Li CKF, Seth R, Balwin TJ, Menozzi MG, Mahida YR (2000) Bacteroides fragilis enterotoxin induces the expression of IL-8 and transforming growth factor-beta (TFG-β) by human colonic epithelial cells. Clin Exp Immunol 119:456–463PubMedCrossRef
44.
Kim JM, Oh YK, Kim YJ, Oh HB, Cho YJ (2001) Polarized secretion of CXC chemokines by human intestinal epithelial cells in response to Bacteroides fragilis enterotoxin: NF-κB plays a major role in the regulation of IL-8 expression. Clin Exp Immunol 123:421–427PubMedCrossRef
45.
Prindiville TP, Sheikh RA, Cohen SH, Tang YJ, Cantrell MC, Silva Jr J (2000) Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg Infect Dis 6:171–174PubMedCrossRef
46.
Wu S, Morin PJ, Maouyo D, Sears CL (2003) Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 124:392–400PubMedCrossRef
47.
Poxton IR, Edmond DM (1995) Biological activity of Bacteroides lipopolysaccharide−reappraisal. Clin Infect Dis 20:S149–S153PubMed
48.
Cummings JH (1981) Short chain fatty acids in the human colon. Gut 22:763–779PubMed
49.
Wächtershäuser A, Stein J (2000) Rationale for the luminal provision of butyrate in intestine disease. Eur J Nutr 39:164–171PubMedCrossRef
50.
Hold GL, Schwiertz A, Aminov RI, Blaut M, Flint HJ (2003) Oligonucleotide probes that detect quantitatively significant groups of butyrate-producing bacteria in human feces. Appl Environ Microbiol 69:4320–4324PubMedCrossRef
51.
Roediger WE (1980) The colonic epthelium in ulcerative colitis: an energy-deficiency disease? Lancet 2:712–715PubMedCrossRef
52.
Scheppach W, Sommer H, Kirchner T, Paganelli GM, Bartram P, Christl S, Richter F, Dusel G, Kasper H (1992) Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology 103:51–56PubMed
53.
Schauber J, Bark T, Jaramillo E, Katouli M, Sandstedt B, Svenberg T (2000) Local short-chain fatty acids supplementation without beneficial effect on inflammation in excluded rectum. Scan J Gastroenterol 35:184–198CrossRef
54.
Steinhart AH, Hiruki T, Brzezinski A, Paker JP (1996) Treatment of left-sided ulcerative colitis with butyrate enemas: a controlled trail. Aliment Pharmacol Ther 10:729–736PubMedCrossRef
55.
Fusunyan RD, Quinn JJ, Ohno Y, MacDermott RP, Sanderson IR (1998) Butyrate enhances interleukin (IL)-8 secretion by intestinal epithelial cells in response to IL-1β and lipopolysaccharide. Pediatr Res 43:84–90PubMed
56.
Keshavarzian A, Fusunyan RD, Jacyno M, Winship D, MacDermott RP, Sanderson IR (1999) Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol 94:704–712PubMedCrossRef
57.
Daig R, Andus T, Aschenbrenner E, Falk W, Scholmerich J, Gross V (1996) Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 38:216–222
58.
Mylonaki M, Langmead L, Pantes A, Johnson F, Rampton DS (2004) Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 16:775–778PubMedCrossRef
Metadata
Title
High Proportions of Proinflammatory Bacteria on the Colonic Mucosa in a Young Patient with Ulcerative Colitis as Revealed by Cloning and Sequencing of 16S rRNA Genes
Authors
Mei Wang
Göran Molin
Siv Ahrné
Diya Adawi
Bengt Jeppsson
Publication date
01-03-2007
Published in
Digestive Diseases and Sciences / Issue 3/2007
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-006-9461-1

Other articles of this Issue 3/2007

Digestive Diseases and Sciences 3/2007 Go to the issue

Original Paper

Patterns of Small Intestinal Motor Activity During Intraluminal Infusion of Elementary Diets in Dogs

Basic Research

Aspirin-Induced Apoptosis in Human Gastric Cancer Epithelial Cells: Relationship with Protein Kinase C Signaling

Original Paper

Elevated Expression of Autocrine Motility Factor Receptor Correlates with Overexpression of RhoC and Indicates Poor Prognosis in Hepatocellular Carcinoma

Original Paper

Continuous Versus Cyclic Mesalazine Therapy for Patients Affected by Recurrent Symptomatic Uncomplicated Diverticular Disease of the Colon

Review Article

Endometrioma of the Large Bowel

Original Paper

Comparison of D-Xylose Hydrogen Breath Test With Urinary D-Xylose Test in Indian Children With Celiac Disease
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits